Medication info
Hiroten Tablets 10/50 mg (Amlodipine, Losartan Potassium)

Hiroten Tablets 10/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Pink oblong film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 201502666 · Approved 2015.04.30 · Insurance code 646004000

Summary

Main use
Essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular effective circulating volume: Administration of this medicine is not recommended in a small number of patients with reduced intravascular effective circulating volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, a starting dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its administration is not recommended.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with either amlodipine or losartan monotherapy. Additionally, it is used as initial treatment in patients with stage 2 hypertension who require combination therapy to reach their target blood pressure. It helps reduce the risk of cardiovascular diseases and improve health through hypertension management.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular effective circulating volume: Administration of this medicine is not recommended in a small number of patients with reduced intravascular effective circulating volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, a starting dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its administration is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should avoid use. If pregnancy is confirmed, this medication should be discontinued immediately, and special care is needed for the health of the fetus and newborn. Patients with reduced intravascular blood volume, such as those taking diuretics, should stabilize their condition before taking this medication and should be cautious as hypotension may occur. Patients allergic to any component of this medication, patients with severely impaired liver function, those with severe aortic stenosis, or those in a state of shock should not use this medication. This drug is used for hypertension treatment, and because of its blood-pressure-lowering effect, dizziness or drowsiness may occur, so driving or operating hazardous machinery is not recommended. Patients with impaired liver or kidney function should take this medication with caution, and regular blood tests are recommended as potassium levels may increase. There may be interactions when used with other antihypertensive agents, potassium-sparing diuretics, or potassium supplements, so consultation with healthcare professionals is essential. Nursing mothers should avoid taking this medication as its components may be passed into breast milk. The safety and efficacy of this medication have not been established in children under 18 years of age, and it is not recommended. Overdose may result in severe hypotension or cardiac arrhythmias, so strict adherence to the prescribed dosage is necessary, and if abnormal symptoms occur, immediate medical attention should be sought. This medication should be kept out of reach of children and should not be transferred to another container.

Side effects

Dizziness, headache, drowsiness, cerebrovascular accident, weakness, chest discomfort, chest pain, early satiety, peripheral edema, pitting edema, abdominal discomfort, dyspepsia, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, dizziness (vertigo), conjunctival injection, increased urination, fatigue, edema, vasculitis, tension increase, sensory loss, sensory abnormalities, peripheral neuropathy, syncope, dysgeusia, tremor, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, alopecia, increased sweating, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary tract dysfunction, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, polymorphic eruption, myocardial infarction, arrhythmia, sinus block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, skin flushing, maculopapular rash, heaviness, heat sensation, impaired glucose tolerance, weakness, muscle cramps, low back pain, leg pain, congestion, upper respiratory infection, sinusitis, diarrhea, sinus disorder, pharyngitis, myalgia, insomnia, edema, abdominal pain, angioedema, skin desquamation, hemolysis, facial edema, fever, orthostatic effects, syncope, angina, second-degree atrioventricular block, cerebrovascular accident, hypotension, atrial fibrillation, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, anorexia, toothache, flatulence, gastritis, anemia, gout, upper limb pain, hip joint pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle rigidity, arthritis, fibromyalgia, muscle weakness, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory diminution, reduced libido, memory impairment, migraine, neural hyperexcitability, panic disorder, sleep disorder, bronchitis, pharyngeal discomfort, epistaxis, respiratory congestion, dermatitis, dry skin, petechial hemorrhage, erythema, photosensitivity, sweating, blurred vision, burning sensation and pain in the eyes, conjunctivitis, taste distortion, tinnitus, decreased vision, nocturia, urethral infection, hypotension, shock symptoms, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylactic syndrome, angioedema (laryngeal/pharyngeal edema that can cause airway obstruction, swelling of the face/lips/throat/tongue), vasculitis, malaise, thrombocytopenia, rhabdomyolysis, dysgeusia, dry cough, erythroderma, hyperkalemia, hyponatremia, elevated ALT, elevated serum creatinine, elevated liver enzymes, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, shock state, hypotension, tachycardia, bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's effectiveness and safety for a long time.

Appearance and packaging

Appearance

Pink oblong film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.